日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

PedVacc 002: a phase I/II randomized clinical trial of MVA.HIVA vaccine administered to infants born to human immunodeficiency virus type 1-positive mothers in Nairobi

PedVacc 002:一项在内罗毕开展的MVA.HIVA疫苗I/II期随机临床试验,受试者为感染1型人类免疫缺陷病毒(HIV-1)母亲所生的婴儿。

Njuguna, Irene N; Ambler, Gwen; Reilly, Marie; Ondondo, Beatrice; Kanyugo, Mercy; Lohman-Payne, Barbara; Gichuhi, Christine; Borthwick, Nicola; Black, Antony; Mehedi, Shams-Rony; Sun, Jiyu; Maleche-Obimbo, Elizabeth; Chohan, Bhavna; John-Stewart, Grace C; Jaoko, Walter; Hanke, Tomáš

A phase I randomized clinical trial of candidate human immunodeficiency virus type 1 vaccine MVA.HIVA administered to Gambian infants

一项针对冈比亚婴儿的候选人类免疫缺陷病毒1型疫苗MVA.HIVA的I期随机临床试验

Afolabi, Muhammed O; Ndure, Jorjoh; Drammeh, Abdoulie; Darboe, Fatoumatta; Mehedi, Shams-Rony; Rowland-Jones, Sarah L; Borthwick, Nicola; Black, Antony; Ambler, Gwen; John-Stewart, Grace C; Reilly, Marie; Hanke, Tomáš; Flanagan, Katie L